Latest New Zealand Market News

Locate Technologies has ended its Australian ATM Facility, initiated a new NZ$10 million facility in New Zealand, and proposed a share buy-back pending shareholder approval, aligning with its Bitcoin Treasury ambitions.

XPON Technologies reports a robust Q1 FY26 with 17.5% revenue growth, positive cash flow, and strategic leadership changes, setting a strong foundation for the year ahead.

Talius Group has raised $4 million in a recent placement, expanding its subscription base and preparing to capitalize on new aged care legislation set to take effect in November 2025.

Delorean Corporation has transitioned to the operations and maintenance phase at its $53 million Yarra Valley Water bioenergy facility, marking a key milestone in its renewable energy expansion.

Amotiv Limited reported steady FY25 financials with marginal revenue growth and a slight EBITA dip, while unveiling its ambitious Amotiv2030 strategy to drive future shareholder value amid ongoing market challenges.

EVT Limited reports a robust 20.7% rise in Q1 EBITDA, driven by all divisions, with Hotels leading record results and a strategic acquisition poised to boost earnings further.

Michael Hill International reported steady FY25 financials amid challenging markets, with early FY26 trading showing promising margin improvements and mixed sales across regions.

Algorae Pharmaceuticals has signed a binding term sheet with India’s Cadila Pharmaceuticals to introduce two generic medicines targeting cardiovascular and metabolic disorders in Australia and New Zealand.

Infratil Limited is expanding its footprint in New Zealand's energy sector by acquiring an additional 4.92% stake in Contact Energy for NZ$437.7 million, combining debt and equity financing.

Tower Limited has raised its full-year profit guidance significantly, driven by lower-than-expected large event costs, even as it moderates its premium growth outlook.

Biome Australia has partnered with Green Cross Health to launch its Activated Probiotics across New Zealand’s largest pharmacy network, marking a pivotal step in its international growth strategy.

RMA Global Ltd reported a 13% revenue increase to $21.1 million in FY25, driven by growth in the US and New Zealand, alongside steady Australian performance. The company also recorded its first full-year positive operating cash flow, marking a significant financial turnaround.